Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Markets
Markets

InterCure Regains Nasdaq Compliance

Sep 8, 2026 · 04:13 PM ET· updated 55m ago

InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) ("InterCure" or the "Company") announced today that it received written confirmation from the Listing Qualifications Department of The Nasdaq Stock Market LLC

Share
Why It Matters

InterCure fixed a problem and got permission to stay listed on Nasdaq, which is like getting your license back after it was suspended. This means the company can keep trading normally, which is good news for people who own the stock.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
INCR5.41
-0.01 (-0.18%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.